KEMRI joins global Dengue research alliance
Kenya has become the first African country to join the global Dengue Alliance, strengthening efforts to improve research, diagnosis and treatment of a mosquito-borne disease whose burden is increasingly being recognised across the continent. The Alliance, established in 2022, brings together research institutions in dengue-endemic countries to accelerate the development of safe, effective and…
Kenya has become the first African country to join the global Dengue Alliance, a research collaboration aimed at improving the diagnosis, treatment, and overall management of dengue fever. Established in 2022, the Alliance brings together institutions from dengue-endemic countries to accelerate the development of safe, effective, and affordable treatments for the mosquito-borne disease.
KEMRI’s membership is expected to enhance research collaboration across Africa and ensure that patients on the continent are included in future clinical studies. Dr. Erick Muok, Acting Director of Research and Development at KEMRI, emphasized that dengue is a growing public health concern in Africa, but its true burden remains underestimated due to underdiagnosis and underreporting.
The organization will contribute African expertise and evidence to strengthen global research, surveillance, diagnostics, and clinical management of the disease.
Brief written by urgent.news from KBC's own syndicated text. Machine-written — may contain errors; check the original before relying on it.
